Radiosynthesis and Evaluation of 5-[I]Iodoindol-3-yl-β--Galactopyranoside as a β-Galactosidase Imaging Radioligand

The synthesis and investigation of 5-[ 125 I]iodoindol-3-yl-β- d -galactopyranoside ([ 125 I]IBDG) as a radioligand for single-photon emission computed tomography (SPECT) imaging of β-galactosidase expression are described. No-carrier-added [ 125 I]IBDG was synthesized by a radioiododestannylation a...

Full description

Saved in:
Bibliographic Details
Main Authors: Marcian E. Van Dort, Kuei C. Lee, Christin A. Hamilton, Alnawaz Rehemtulla, Brian D. Ross
Format: Article
Language:English
Published: SAGE Publishing 2008-07-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2008.00020
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841563145366142976
author Marcian E. Van Dort
Kuei C. Lee
Christin A. Hamilton
Alnawaz Rehemtulla
Brian D. Ross
author_facet Marcian E. Van Dort
Kuei C. Lee
Christin A. Hamilton
Alnawaz Rehemtulla
Brian D. Ross
author_sort Marcian E. Van Dort
collection DOAJ
description The synthesis and investigation of 5-[ 125 I]iodoindol-3-yl-β- d -galactopyranoside ([ 125 I]IBDG) as a radioligand for single-photon emission computed tomography (SPECT) imaging of β-galactosidase expression are described. No-carrier-added [ 125 I]IBDG was synthesized by a radioiododestannylation approach in > 75% overall radiochemical yield and > 99% radiochemical purity. [ 125 I]IBDG was evaluated as a substrate using β-galactosidase-expressing (D54L) and nonexpressing (D54) human glioma cell lines. A 24-hour incubation of this substrate with cultured cells revealed a 6.5-fold greater intracellular trapping of radioactivity in D54L cells compared with D54 cells. Systemic delivery of [ 125 I]IBDG in nude mice bearing D54L tumors failed to show significant trapping of radioactivity within these tumors by SPECT imaging. In contrast, intratumoral injection of the substrate resulted in efficient trapping of radioactivity in D54L tumors but not D54 tumors, resulting in clear SPECT visualization of the former tumor. Based on dynamic SPECT imaging and blood metabolite analysis, we conclude that although [ 125 I]IBDG is an efficient in vivo substrate for β-galactosidase, its rapid renal clearance hampers its intratumoral availability on systemic administration.
format Article
id doaj-art-6608c15e64fe43f690e1d1be11ae11ea
institution Kabale University
issn 1536-0121
language English
publishDate 2008-07-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-6608c15e64fe43f690e1d1be11ae11ea2025-01-03T00:11:02ZengSAGE PublishingMolecular Imaging1536-01212008-07-01710.2310/7290.2008.0002010.2310_7290.2008.00020Radiosynthesis and Evaluation of 5-[I]Iodoindol-3-yl-β--Galactopyranoside as a β-Galactosidase Imaging RadioligandMarcian E. Van DortKuei C. LeeChristin A. HamiltonAlnawaz RehemtullaBrian D. RossThe synthesis and investigation of 5-[ 125 I]iodoindol-3-yl-β- d -galactopyranoside ([ 125 I]IBDG) as a radioligand for single-photon emission computed tomography (SPECT) imaging of β-galactosidase expression are described. No-carrier-added [ 125 I]IBDG was synthesized by a radioiododestannylation approach in > 75% overall radiochemical yield and > 99% radiochemical purity. [ 125 I]IBDG was evaluated as a substrate using β-galactosidase-expressing (D54L) and nonexpressing (D54) human glioma cell lines. A 24-hour incubation of this substrate with cultured cells revealed a 6.5-fold greater intracellular trapping of radioactivity in D54L cells compared with D54 cells. Systemic delivery of [ 125 I]IBDG in nude mice bearing D54L tumors failed to show significant trapping of radioactivity within these tumors by SPECT imaging. In contrast, intratumoral injection of the substrate resulted in efficient trapping of radioactivity in D54L tumors but not D54 tumors, resulting in clear SPECT visualization of the former tumor. Based on dynamic SPECT imaging and blood metabolite analysis, we conclude that although [ 125 I]IBDG is an efficient in vivo substrate for β-galactosidase, its rapid renal clearance hampers its intratumoral availability on systemic administration.https://doi.org/10.2310/7290.2008.00020
spellingShingle Marcian E. Van Dort
Kuei C. Lee
Christin A. Hamilton
Alnawaz Rehemtulla
Brian D. Ross
Radiosynthesis and Evaluation of 5-[I]Iodoindol-3-yl-β--Galactopyranoside as a β-Galactosidase Imaging Radioligand
Molecular Imaging
title Radiosynthesis and Evaluation of 5-[I]Iodoindol-3-yl-β--Galactopyranoside as a β-Galactosidase Imaging Radioligand
title_full Radiosynthesis and Evaluation of 5-[I]Iodoindol-3-yl-β--Galactopyranoside as a β-Galactosidase Imaging Radioligand
title_fullStr Radiosynthesis and Evaluation of 5-[I]Iodoindol-3-yl-β--Galactopyranoside as a β-Galactosidase Imaging Radioligand
title_full_unstemmed Radiosynthesis and Evaluation of 5-[I]Iodoindol-3-yl-β--Galactopyranoside as a β-Galactosidase Imaging Radioligand
title_short Radiosynthesis and Evaluation of 5-[I]Iodoindol-3-yl-β--Galactopyranoside as a β-Galactosidase Imaging Radioligand
title_sort radiosynthesis and evaluation of 5 i iodoindol 3 yl β galactopyranoside as a β galactosidase imaging radioligand
url https://doi.org/10.2310/7290.2008.00020
work_keys_str_mv AT marcianevandort radiosynthesisandevaluationof5iiodoindol3ylbgalactopyranosideasabgalactosidaseimagingradioligand
AT kueiclee radiosynthesisandevaluationof5iiodoindol3ylbgalactopyranosideasabgalactosidaseimagingradioligand
AT christinahamilton radiosynthesisandevaluationof5iiodoindol3ylbgalactopyranosideasabgalactosidaseimagingradioligand
AT alnawazrehemtulla radiosynthesisandevaluationof5iiodoindol3ylbgalactopyranosideasabgalactosidaseimagingradioligand
AT briandross radiosynthesisandevaluationof5iiodoindol3ylbgalactopyranosideasabgalactosidaseimagingradioligand